Impact of Comorbid COVID-19 and Substance Use During Pregnancy on Fetal and Infant Development Workshop
Wednesday, July 20, 2022 10:00am to 5:00pm
NIDA Brain Development Research Consortium
Numerous underlying medical conditions are associated with worse outcomes for those infected with SARS-CoV-2, including pregnancy and recent pregnancy (defined as at least 42 days following the end of pregnancy).